Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
‘We’ve never had a technology like Crispr before’: gene-editing moves into the clinic
Crispr moves into the clinic | News | Chemistry World
EC approves first allogeneic T cell therapy for rare post-transplant complication
After prior rejection, Ferring finally nabs FDA nod for bladder cancer gene therapy
After prior rejection, Ferring finally nabs FDA nod for bladder cancer gene therapy | Fierce Pharma
Kite swoops in to buy Carl June-founded Tmunity, gaining key to Penn's CAR-T research apparatus
Gilead's Kite swoops in to buy CAR-T focused Tmunity (fiercebiotech.com)
Cancer center leaders lay bare CAR-T makers' struggles—and an unexpected laggard
Cancer center leaders lay bare CAR-T makers’ struggles (fiercepharma.com)
New Biomarker Found That Could Potentially Aid Early Screening for Dementia
Emerging immunomodulatory strategies for cell therapeutics
Emerging immunomodulatory strategies for cell therapeutics: Trends in Biotechnology
Challenges and opportunities in bringing nonbiological atoms to life with synthetic metabolism
In a first, children with rare genetic diseases get mitochondrial transplants from their mothers
Kids with rare diseases get mitochondria from their mothers - STAT (statnews.com)
Scientists Created Male and Female Cells from a Single Person
Cells with XX or XY chromosomes provide researchers with a new tool to study how differences in sex chromosomes can influence health and development
Scientists Created Male and Female Cells from a Single Person - Scientific American
Brain Monitoring Could Prevent Most Neurological and Psychiatric Illnesses
By crunching data from molecular tests, cognitive assessments and medical history, doctors could one day intervene and prevent brain disease.
Brain Monitoring Could Prevent Most Neurological and Psychiatric Illnesses - Scientific American
Gene therapy restored immune system in children with rare disorder
10 children with the rare condition Artemis-deficient severe combined immunodeficiency had their immune systems either partially or fully restored with gene-replacement therapy
SCID: Gene therapy restored immune system in children with rare disorder | New Scientist
Scientists tie third clinical trial death to experimental Alzheimer’s drug
Amid lobbying for lecanemab’s approval, a newly revealed death adds to doubts about safety of anti-amyloid antibody
Scientists tie third clinical trial death to experimental Alzheimer’s drug | Science | AAAS